Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-03-25

Clinical Trial Update: Chidamide Combination With R-mini CHOP Followed by Chidamide+CD20 Maintenance in Elderly Newly Diagnosed MYC/BCL2+ DLBCL [Phase 2]

View source ↗

Summary

A Phase 2 trial is evaluating chidamide in combination with R-mini CHOP followed by chidamide plus CD20 maintenance in elderly patients with newly diagnosed MYC…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Chidamide (chidamide)
  • Rituximab (rituximab)

Snippet

Sponsor: Ou Bai, MD/PHD | Conditions: Diffuse Large B-Cell Lymphoma (DLBCL) | Phase 2 | Status: RECRUITING